Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL

Ibrutinib, a Bruton tyrosine kinase inhibitor, provides effective treatment for chronic lymphocytic leukemia (CLL). Here, the authors describe time-dependent molecular changes to malignant cells and to the immune system in patients undergoing ibrutinib therapy, with can be used for therapy monitorin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: André F. Rendeiro, Thomas Krausgruber, Nikolaus Fortelny, Fangwen Zhao, Thomas Penz, Matthias Farlik, Linda C. Schuster, Amelie Nemc, Szabolcs Tasnády, Marienn Réti, Zoltán Mátrai, Donát Alpár, Csaba Bödör, Christian Schmidl, Christoph Bock
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/73b869eadff94edea5bfbf6a4cfbce75
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:73b869eadff94edea5bfbf6a4cfbce75
record_format dspace
spelling oai:doaj.org-article:73b869eadff94edea5bfbf6a4cfbce752021-12-02T17:32:59ZChromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL10.1038/s41467-019-14081-62041-1723https://doaj.org/article/73b869eadff94edea5bfbf6a4cfbce752020-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-14081-6https://doaj.org/toc/2041-1723Ibrutinib, a Bruton tyrosine kinase inhibitor, provides effective treatment for chronic lymphocytic leukemia (CLL). Here, the authors describe time-dependent molecular changes to malignant cells and to the immune system in patients undergoing ibrutinib therapy, with can be used for therapy monitoring.André F. RendeiroThomas KrausgruberNikolaus FortelnyFangwen ZhaoThomas PenzMatthias FarlikLinda C. SchusterAmelie NemcSzabolcs TasnádyMarienn RétiZoltán MátraiDonát AlpárCsaba BödörChristian SchmidlChristoph BockNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
André F. Rendeiro
Thomas Krausgruber
Nikolaus Fortelny
Fangwen Zhao
Thomas Penz
Matthias Farlik
Linda C. Schuster
Amelie Nemc
Szabolcs Tasnády
Marienn Réti
Zoltán Mátrai
Donát Alpár
Csaba Bödör
Christian Schmidl
Christoph Bock
Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL
description Ibrutinib, a Bruton tyrosine kinase inhibitor, provides effective treatment for chronic lymphocytic leukemia (CLL). Here, the authors describe time-dependent molecular changes to malignant cells and to the immune system in patients undergoing ibrutinib therapy, with can be used for therapy monitoring.
format article
author André F. Rendeiro
Thomas Krausgruber
Nikolaus Fortelny
Fangwen Zhao
Thomas Penz
Matthias Farlik
Linda C. Schuster
Amelie Nemc
Szabolcs Tasnády
Marienn Réti
Zoltán Mátrai
Donát Alpár
Csaba Bödör
Christian Schmidl
Christoph Bock
author_facet André F. Rendeiro
Thomas Krausgruber
Nikolaus Fortelny
Fangwen Zhao
Thomas Penz
Matthias Farlik
Linda C. Schuster
Amelie Nemc
Szabolcs Tasnády
Marienn Réti
Zoltán Mátrai
Donát Alpár
Csaba Bödör
Christian Schmidl
Christoph Bock
author_sort André F. Rendeiro
title Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL
title_short Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL
title_full Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL
title_fullStr Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL
title_full_unstemmed Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL
title_sort chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in cll
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/73b869eadff94edea5bfbf6a4cfbce75
work_keys_str_mv AT andrefrendeiro chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT thomaskrausgruber chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT nikolausfortelny chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT fangwenzhao chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT thomaspenz chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT matthiasfarlik chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT lindacschuster chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT amelienemc chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT szabolcstasnady chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT mariennreti chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT zoltanmatrai chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT donatalpar chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT csababodor chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT christianschmidl chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
AT christophbock chromatinmappingandsinglecellimmuneprofilingdefinethetemporaldynamicsofibrutinibresponseincll
_version_ 1718380127803408384